go back

Indium In-111 Ibritumomab Tiuxetan, Diagnostic

Louisiana rates for HCPCS A9542

Indium In-111 ibritumomab tiuxetan, diagnostic, per study dose, up to 5 mCi

Rates data updated July 2026.

Facilitymedian $3,802 · 10th–90th $2,570$3,8020%50%10th$3,802Professionalmedian $3,236 · 10th–90th $2,692$4,1690%20%10th90th$3,236$2.0K$5.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$2,570.40
Median
$3,235.94
Typical High
$3,801.89
Aetna
Setting
Professional
Modifier
Global
Typical Low
$2,398.83
Median
$3,019.95
Typical High
$3,311.31
BCBS
Setting
Facility
Modifier
Global
Typical Low
$3,801.89
Median
$3,801.89
Typical High
$3,801.89
BCBS
Setting
Professional
Modifier
Global
Typical Low
$3,801.89
Median
$3,801.89
Typical High
$3,801.89
Cigna
Setting
Facility
Modifier
Global
Typical Low
$3,548.13
Median
$4,168.69
Typical High
$7,079.46
Cigna
Setting
Professional
Modifier
Global
Typical Low
$3,548.13
Median
$3,548.13
Typical High
$3,548.13
United
Setting
Facility
Modifier
Global
Typical Low
$3,467.37
Median
$4,073.80
Typical High
$5,011.87
United
Setting
Professional
Modifier
Global
Typical Low
$4,168.69
Median
$4,168.69
Typical High
$4,466.84